A new trading day began on Friday, with Macrogenics Inc (NASDAQ: MGNX) stock price up 17.36% from the previous day of trading, before settling in for the closing price of $1.44. MGNX’s price has ranged from $0.99 to $5.10 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 19.47% over the past five years. Meanwhile, its annual earnings per share averaged -63.44%. With a float of $58.16 million, this company’s outstanding shares have now reached $63.21 million.
Macrogenics Inc (MGNX) Insider Updates
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Macrogenics Inc is 7.98%, while institutional ownership is 71.35%. The most recent insider transaction that took place on Aug 19 ’25, was worth 76,760. In this transaction Director of this company bought 50,500 shares at a rate of $1.52, taking the stock ownership to the 61,500 shares. Before that another transaction happened on Aug 20 ’25, when Company’s Director bought 49,500 for $1.49, making the entire transaction worth $73,755. This insider now owns 111,000 shares in total.
Macrogenics Inc (MGNX) Performance Highlights and Predictions
In its latest quarterly report, released on 9/30/2024, the company reported earnings of 0.9 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.15 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -63.44% per share during the next fiscal year.
Macrogenics Inc (NASDAQ: MGNX) Trading Performance Indicators
Here are Macrogenics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 5.02. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.65.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.57, a number that is poised to hit -0.41 in the next quarter and is forecasted to reach -1.59 in one year’s time.
Technical Analysis of Macrogenics Inc (MGNX)
Macrogenics Inc (NASDAQ: MGNX) saw its 5-day average volume 0.66 million, a negative change from its year-to-date volume of 0.91 million. As of the previous 9 days, the stock’s Stochastic %D was 41.82%.
During the past 100 days, Macrogenics Inc’s (MGNX) raw stochastic average was set at 59.32%, which indicates a significant decrease from 91.23% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.1149 in the past 14 days, which was lower than the 0.1317 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.5068, while its 200-day Moving Average is $2.2321. Nevertheless, the first resistance level for the watch stands at $1.7567 in the near term. At $1.8233, the stock is likely to face the second major resistance level. The third major resistance level sits at $1.9467. If the price goes on to break the first support level at $1.5667, it is likely to go to the next support level at $1.4433. Assuming the price breaks the second support level, the third support level stands at $1.3767.
Macrogenics Inc (NASDAQ: MGNX) Key Stats
With a market capitalization of 106.82 million, the company has a total of 63,206K Shares Outstanding. Currently, annual sales are 149,960 K while annual income is -66,970 K. The company’s previous quarter sales were 22,240 K while its latest quarter income was -36,250 K.
